SENZAGEN
LIVE

Serial Number

79258436

Owner

SenzaGen AB

Attorney

Bradley L. Cohn

Filing Date

Nov 17, 2017

Add to watchlist:

No watchlists yet
View on USPTO

SENZAGEN Trademark

Serial Number: 79258436 • Registration: 6187125

SENZAGEN is a trademark filed by SenzaGen AB on November 17, 2017. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

SenzaGen AB (3 trademarks)

Medicon Village, Scheelevägen 2

Entity Type: 64

Trademark Details

Filing Date

November 17, 2017

Registration Date

November 3, 2020

Published for Opposition

August 18, 2020

Goods & Services

Diagnostic preparations for analysis of toxicological properties of chemical compounds and mixtures for scientific testing and screening purposes, performed in laboratories, research and scientific use; assays for analysis of toxicological properties of chemical compounds and mixtures for scientific testing and screening purposes, performed in laboratories, research and scientific use; diagnostic biomarkers for analysis of toxicological properties of chemical compounds and mixtures for scientific testing and screening purposes, performed in laboratories, research and scientific use; diagnostic preparations, assays and biomarkers for use in in vitro testing, assessment of toxicological properties of chemical compounds and mixtures, genomic analysis, assessment of chemical skin sensitizers, respiratory sensitizers and potency classification of chemicals, chemical compounds and mixtures, chemical sensitizers, agrochemicals, industrial chemicals, natural extracts, cosmetics and cosmetic ingredients, pharmaceuticals and pharmaceutical candidates, medical devices and materials, consumer products, for scientific testing and screening purposes, performed in laboratories for scientific testing and screening purposes; diagnostic preparations, assays and biomarkers for screening of pharmaceutical candidates, safety and potency classification of chemicals, safety and potency testing of cosmetic ingredients and assessment of sensitizers for industry and regulatory purposes, for scientific testing and screening purposes, and not for medical or veterinary use

In vitro testing for medical and pharmaceutical diagnostic purposes; allergy testing and animal-free allergy testing, all for medical and pharmaceutical diagnostic purposes; information, advisory and consultancy services relating thereto

Scientific and technological services, namely, research and design in the field of genomics, in vitro and animal free testing, testing of toxicological properties of chemical compounds and mixtures and chemical sensitizers, screening of products, materials and substances for sensitizers, allergens and potency classification; scientific industrial analysis and research services in the field of genomics, in vitro and animal free testing, testing of toxicological properties of chemical compounds and mixtures and chemical sensitizers, screening of products, materials and substances for sensitizers, allergens and potency classification; scientific research and development; conducting research in the field of genomics and animal-free product testing; laboratory services in the field of genomics and animal-free product testing; in vitro analysis and dermal and respiratory analysis of chemicals, chemical compounds and mixtures, chemical sensitizers, agrochemicals, industrial chemicals, natural extracts, cosmetics and cosmetic ingredients, pharmaceuticals and pharmaceutical candidates, medical devices and materials, consumer products for scientific, medical and pharmaceutical research purposes; assessment of toxicological properties of chemical compounds and mixtures, for medical, pharmaceutical and scientific research services and for medical research and scientific research purposes; in vitro skin and respiratory sensitization analysis of chemicals, chemical compounds and mixtures, chemical sensitizers, agrochemicals, industrial chemicals, natural extracts, cosmetics and cosmetic ingredients, pharmaceuticals and pharmaceutical candidates, medical devices and materials, consumer products, for medical, pharmaceutical and scientific research services and for medical research and scientific research purposes; in vitro safety assessments of chemicals, chemical compounds and mixtures, chemical sensitizers, agrochemicals, industrial chemicals, natural extracts, cosmetics and cosmetic ingredients, pharmaceuticals and pharmaceutical candidates, medical devices and materials, consumer products, for medical, pharmaceutical and scientific research services and for medical research and scientific research purposes; in vitro testing for assessment of chemical skin sensitizers, respiratory sensitizers and potency classification for scientific, medical and pharmaceutical research services and for medical research and scientific research purposes; allergy analysis and animal-free allergy analysis of consumer products, chemical products, cosmetic products, pharmaceutical products and medical products for medical and pharmaceutical purposes; custom development of sensitization assays for prediction and classification of chemical sensitizers; safety and potency classification of chemicals, for medical, pharmaceutical and scientific research services; safety and potency testing of cosmetic ingredients; assessment of sensitizers for industry product testing and regulatory purposes in the medical and pharmaceutical industries; safety assessments of chemicals and proteins in the medical and pharmaceutical industries; in vitro product testing assessment of allergens, in the medical and pharmaceutical industries; sensitization product testing for the pharmaceutical, cosmetic and chemical industry; information, advisory and consultancy services relating to genomics, in vitro and animal free testing, testing of toxicological properties of chemical compounds and mixtures and chemical sensitizers, screening of products, materials and substances for sensitizers, allergens and potency classification, product testing assessment of toxicological properties of chemical compounds and mixtures for medical and pharmaceutical research purposes; animal-free product testing of chemical compounds, genomic product testing, animal-free genomic product testing, dermal and respiratory in vitro product testing and analysis, in vitro skin and respiratory sensitization product testing and analysis, in vitro product safety assessments, product testing and assessment of sensitizers, in vitro product testing for assessment of chemical skin sensitizers, respiratory sensitizers and potency classification, all for medical and pharmaceutical product safety purposes; screening of pharmaceutical candidates, safety and potency classification of chemicals, safety and potency testing of cosmetic ingredients and assessment of sensitizers for industry and regulatory purposes in the medical and pharmaceutical industries and for medical research and scientific research purposes; safety assessment of chemicals and proteins, in vitro assessment of allergens, all for medical and pharmaceutical purposes and for medical research and scientific research purposes; sensitization product testing for the pharmaceutical and cosmetic industries; in vitro safety and toxicity testing of medical devices

Diagnostic preparations for medical use; assays for medical use; diagnostic biomarkers for medical use; diagnostic preparations, assays and biomarkers for use in in vitro testing, assessment of toxicological properties of chemical compounds and mixtures, genomic analysis, assessment of chemical skin sensitizers, respiratory sensitizers and potency classification, all for medical testing and screening purposes; diagnostic preparations, assays and biomarkers for screening of pharmaceutical candidates, safety and potency classification of chemicals, safety and potency testing of cosmetic ingredients and assessment of sensitizers for industry and regulatory purposes in the medical and pharmaceutical industries, all for medical and pharmaceutical medical-based testing and screening purposes

Filing History

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Nov 3, 2025 REM3
NEW REPRESENTATIVE AT IB RECEIVED
Apr 2, 2023 NREP
NEW REPRESENTATIVE AT IB RECEIVED
Jan 29, 2023 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Mar 7, 2021 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Feb 13, 2021 FICS
FINAL DISPOSITION PROCESSED
Feb 13, 2021 FIMP
LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED
Feb 3, 2021 LIMN
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Feb 3, 2021 FICR
REGISTERED-PRINCIPAL REGISTER
Nov 3, 2020 R.PR
ATTORNEY REVIEW COMPLETED
Oct 8, 2020 ATRV
CORRECTION FROM IB ENTERED - ATTORNEY REVIEW REQUIRED
Aug 19, 2020 CREV
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 18, 2020 NPUB
PUBLISHED FOR OPPOSITION
Aug 18, 2020 PUBO
NOTIFICATION PROCESSED BY IB
Aug 14, 2020 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jul 29, 2020 OPNS
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 29, 2020 NONP
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Jul 29, 2020 OP2R
LIMITATION OF GOODS RECEIVED FROM IB
Jul 24, 2020 LIMG
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 16, 2020 CNSA
EXAMINER'S AMENDMENT ENTERED
Jul 16, 2020 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jul 16, 2020 GNEN
EXAMINERS AMENDMENT E-MAILED
Jul 16, 2020 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jul 16, 2020 CNEA
CORRECTION TRANSACTION RECEIVED FROM IB
Jul 10, 2020 CRCV
NOTIFICATION OF FINAL REFUSAL EMAILED
Jan 29, 2020 GNFN
FINAL REFUSAL E-MAILED
Jan 29, 2020 GNFR
FINAL REFUSAL WRITTEN
Jan 29, 2020 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 23, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 23, 2019 CRFA
ASSIGNED TO LIE
Dec 23, 2019 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 9, 2019 TROA
REFUSAL PROCESSED BY IB
Jul 5, 2019 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jun 8, 2019 RFCS
REFUSAL PROCESSED BY MPU
Jun 8, 2019 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
May 21, 2019 RFCR
NON-FINAL ACTION WRITTEN
May 20, 2019 CNRT
APPLICATION FILING RECEIPT MAILED
May 14, 2019 MAFR
ASSIGNED TO EXAMINER
May 10, 2019 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 10, 2019 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
May 9, 2019 REPR